Previous Close | 22.08 |
Open | 22.15 |
Bid | 22.12 x N/A |
Ask | 22.18 x N/A |
Day's Range | 22.15 - 22.15 |
52 Week Range | 21.89 - 25.11 |
Volume | |
Avg. Volume | 704 |
Net Assets | 52.13M |
NAV | 22.12 |
PE Ratio (TTM) | N/A |
Yield | 2.34% |
YTD Daily Total Return | -10.24% |
Beta (5Y Monthly) | 0.00 |
Expense Ratio (net) | 0.63% |
Inception Date | 2020-01-23 |
National Bank Investments Inc. (NBI) announced today the May 2022 cash distribution amounts per unit for certain exchange-traded funds (ETF), as indicated in the table below.
BERKELEY HEIGHTS, N.J. , May 03, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report its financial results for the first quarter ended March 31, 2022, after the market close on Thursday, May 12, 2022, and will host a corporate update conference call at 4:30pm Eastern Time. Thursday, May 12th @ 4:
National Bank Investments Inc. (NBI) announced today the March 2022 cash distribution amounts per unit for certain exchange-traded funds (ETF), as indicated in the table below.